跳转至内容
Merck
CN

K1515

Sigma-Aldrich

Anti-Kallikrein 11 antibody produced in rabbit

~1 mg/mL, affinity isolated antibody, buffered aqueous solution

登录查看公司和协议定价

别名:
Anti-Hippostasin, Anti-KLK11
UNSPSC代码:
12352203
NACRES:
NA.41

生物来源

rabbit

质量水平

偶联物

unconjugated

抗体形式

affinity isolated antibody

抗体产品类型

primary antibodies

克隆

polyclonal

形式

buffered aqueous solution

分子量

antigen ~35 kDa

种属反应性

rat, mouse, human

浓度

~1 mg/mL

技术

immunohistochemistry: suitable
western blot: 1:500-1:1,000

UniProt登记号

运输

dry ice

储存温度

−20°C

基因信息

human ... KLK11(11012)
mouse ... Klk11(56538)
rat ... Klk11(292849)

一般描述

The gene KLK11 (kallikrein 11) encodes a member of the kallikrein gene family. The gene is mapped to human chromosome 19q13.4. It is found to be highly expressed in the prostate. It has been found to be present in biological fluids and in serum of patients with various cancers. KLK11 is also found to be expressed in stomach, trachea, skin, and colon.

免疫原

synthetic peptide corresponding to residues 68-82 of the human Kallikrein 11. This sequence is 86% identical in mouse and rat.

生化/生理作用

The gene KLK11 (kallikrein 11) encodes a putative serine protease that is overexpressed in prostate and ovarian cancer. It serves as a biomarker for prognosis of ovarian cancer. It can serve as a marker for distinguishing between prostate cancer and benign prostatic hyperplasia.

外形

solution in phosphate buffered saline, containing 0.02% sodium azide.

WGK

nwg

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

法规信息

新产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma.
Diamandis EP
Cancer Research, 62, 295-300 (2002)
The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia.
Nakamura T
Cancer Research, 63, 6543-6546 (2003)
Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients.
Diamandis EP
Clinical Biochemistry, 37, 823-829 (2004)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门